Scottish medical imaging company Voxar is planning to raise $7.5 million to fund growth in the U.S. and Japan and is considering going public sometime in the next two years.Voxar recently announced an agreement with Japanese distributor Kanagawa to
Scottish medical imaging company Voxar is planning to raise $7.5 million to fund growth in the U.S. and Japan and is considering going public sometime in the next two years.
Voxar recently announced an agreement with Japanese distributor Kanagawa to handle its medical 3-D imaging software, Plug n View, which can be used on standard PC hardware. Voxar said it expects to generate around $3 million in revenue in Japan over the next three years.
Andrew Bissell, its CEO, founded the company in 1995 in Edinburgh. Voxar has about 40 employees with offices in the U.S., Asia Pacific, and Europe, and hopes to double that staff in the near future.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.